Delivery Order SPE2DB20D9331-SPE2DB25FL1W1
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on August 12, 2025. The delivery order, which will be completed by September 3, 2025, covers the supply of Stelara 90 mg/mL syringes, a biologic medication used to treat autoimmune conditions. This award carries no set-aside designation and represents a direct transaction under...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $97,499.70 by the Defense Logistics Agency (DLA) on August 8, 2025. This firm fixed-price delivery order is for the supply of Stelara 90 mg/ml syringes, with an ultimate completion date of August 29, 2025. The contract utilizes no set-aside designation, demonstrating the company's competitive positioning in federal procurement markets. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on August 12, 2025. The delivery order, which is expected to be completed by September 3, 2025, covers the supply of Stelara 90 mg/ml syringes to support Department of Defense healthcare facilities. This award was issued without a set-aside designation, demonstrating the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency on July 24, 2025. The delivery order, issued under the SPE2DB Indefinite Delivery Contract program (valued at $499,999,999 through November 2026), calls for the delivery of Stelara 90 mg/mL syringes to support Department of Defense medical supply requirements. The contract carries no...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $97,499.70 by the Defense Logistics Agency (DLA) on August 29, 2025. The delivery order covers the supply of Stelara 90 mg/mL syringes, a biologic medication used to treat autoimmune conditions. The award was issued without a set-aside designation, demonstrating the company's competitive strength in federal pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $32,499.90 firm fixed-price delivery order by the Defense Logistics Agency on August 5, 2025, for the supply of Stelara 90 mg/ml syringes. The contract contains no set-aside designation and is scheduled for completion by August 26, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $48,749.85 by the Defense Logistics Agency (DLA) on July 31, 2025. The delivery order, with an ultimate completion date of August 21, 2025, covers the supply of Stelara 90 mg/ml syringes—a prescription biologic medication used primarily for treating inflammatory conditions. This award carries no set-aside designation,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency for STELARA 90 MG/ML syringes. This firm fixed-price delivery order, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, represents a specific pharmaceutical procurement under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on July 18, 2025. The delivery order, which must be completed by August 8, 2025, is for Stelara 90 mg/mL syringes and was issued without a set-aside designation. This award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 12, 2025, for the supply of Stelara 90 mg/mL syringes under a firm fixed-price contract valued at $16,249.95. The order is set to be completed by September 3, 2025, with performance taking place at the contractor's facility in Park Ridge, Illinois. This delivery order was issued by the Medical Supply Chain, a defense-focused federal agency,...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB25FL1W1Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $65.0K by the Defense Logistics Agency on August 29, 2025, for the supply of Stelara 90 mg/mL syringes. The contract carries no set-aside designation and is scheduled for completion by September 22, 2025, with performance taking place in Park Ridge, Illinois. This delivery order represents a tactical fulfillment of pharmaceutical supply needs within the Defense Logistics Agency's broader medical distribution operations. This award is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $500.0M through the SPE2DB program, which extends through November 2026. The IDC authorizes the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure recurring contracts for branded and generic prescription drugs, biologics, and medical consumables essential to military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $65.0k | 8/29/25 |